C Laser Enters Federal Lobbying on Authorization Request

Why It Matters

C Laser Inc. filed a new client registration with Barnes & Thornburg LLP on Oct. 20, its first federal lobbying engagement on record, focused on Health Issues and specifically an FDA regulatory authorization request. The sole lobbyist is Eddie Ayoob, Partner/Chair of the firm's Federal Relations Group and a former Legislative Counsel to Sen. Harry Reid (D-NV). ​

By the Numbers

C Laser Inc.'s third-quarter report discloses $10,000 in lobbying spending on the FDA regulatory authorization request under Health Issues. The registration itself carries a $0 filing amount and lists no specific issues or bills.

Broader Context

The Food and Drug Administration (FDA) identifies lasers among the radiation-emitting products regulated by its Center for Devices and Radiological Health, with requirements that may include establishment registration, device listing, premarket review, quality-system rules, labeling, and adverse-event reporting, according to FDA. FDA held a public meeting on Aug. 5 on proposed recommendations for reauthorizing the Medical Device User Fee Amendments (MDUFA) for fiscal years 2028 through 2032; the current authority expires Sept. 30, 2027, after which new legislation will be needed for FDA to continue collecting device user fees, according to FDA.